A clinical trial showed that Lilly's weight loss medicine is superior to a key competitor's product. Eli Lilly (NYSE: LLY) is ...

Breed’s Hill Capital LLC more than tripled its stake in Eli Lilly during Q4, gobbling up 1,426 shares and pushing the company ...

This was the stock's fourth consecutive day of losses.

Investors usually focus on stocks that already have stellar dividend yields, but your portfolio could also benefit from ...

Within the PGIM Quant Solutions Large-Cap Core Fund, growth factors underperformed across large- and mid-cap portfolios in Q1 ...

The PGIM Jennison Growth Fund returned - $10.0%, matching the Russell 1000 Growth Index, which also returned -10.0% in Q1 ...

The "Barrett's Esophagus - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Barrett's Esophagus was valued at US$4.9 Billion in 2024 and is ...